Effective components and mechanism of Qijiao Shengbai Capsules based on fingerprinting and network pharmacology.
10.19540/j.cnki.cjcmm.20221127.301
- Author:
Qian WANG
1
;
Jun JIANG
2
;
Xia XU
1
;
Shi-Lin ZHANG
3
;
Li LIU
3
;
Qing-Qing SONG
1
;
Jun LI
1
Author Information
1. Modern Research Center for Traditional Chinese Medicine,School of Chinese Materia Medica,Beijing University of Chinese Medicine Beijing 102488,China.
2. Shandong Institute for Food and Drug Control Ji'nan 250100,China.
3. Guizhou Hanfang Pharmaceutical Co.,Ltd. Guiyang 550000,China.
- Publication Type:Journal Article
- Keywords:
Qijiao Shengbai Capsules;
cancer;
fingerprints;
leukopenia;
network pharmacology
- MeSH:
Network Pharmacology;
Capsules;
Molecular Docking Simulation;
Phosphatidylinositol 3-Kinases;
Drugs, Chinese Herbal/pharmacology*
- From:
China Journal of Chinese Materia Medica
2023;48(6):1526-1534
- CountryChina
- Language:Chinese
-
Abstract:
Qijiao Shengbai Capsules(QJ) can invigorate Qi and replenish the blood, which is commonly used clinically for adjuvant treatment of cancer and leukopenia due to chemoradiotherapy. However, the pharmacological mechanism of QJ is still unclear. This work aims to combine the high-performance liquid chromatography(HPLC) fingerprints and network pharmacology to clarify the effective components and mechanism of QJ. The HPLC fingerprints of 20 batches of QJ were established. The similarity evaluation among 20 batches of QJ was performed by using Similarity Evaluation System for Chromatographic Fingerprint of Traditional Chinese Medicine(version 2012), resulting in a similarity greater than 0.97. Eleven common peaks were identified by reference standard, including ferulic acid, calycosin 7-O-glucoside, ononin, calycosin, epimedin A, epimedin B, epimedin C, icariin, formononetin, baohuoside I, and Z-ligustilide. The "component-target-pathway" network was constructed by network pharmacy, and 10 key components in QJ were identified, such as ferulic acid, calycosin 7-O-glucoside, ononin, and calycosin. The components were involved in the phosphoinositide 3 kinase-protein kinase B(PI3K-Akt), mitogen-activated protein kinase(MAPK), and other signaling pathways by regulating potential targets, including EGFR, RAF1, PIK3R1, and RELA, to auxiliarily treat tumors, cancers, and leukopenia. The molecular docking conducted on the AutoDock Vina platform confirmed the high binding activity of 10 key effective components with core targets, with the binding energy less than-5 kcal·mol~(-1). In this study, the effective components and mechanism of QJ have been preliminary revealed based on HPLC fingerprint and network pharmacology, which provided a basis for quality control of QJ and a refe-rence for further study on its mechanism.
